Botulinum toxin type A in the treatment of Raynaud's phenomenon
| Autor: | Jeska K de Vries-Bouwstra, Maarten H. Vermeer, Peter J. Velthuis, S Meelad Habib, Elian E A Brenninkmeijer |
|---|---|
| Přispěvatelé: | Dermatology |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Dermatology Fingers 030207 dermatology & venereal diseases 03 medical and health sciences Therapeutic approach 0302 clinical medicine medicine Humans pain botulinum toxin Botulinum Toxins Type A vasospastic business.industry Treatment options Raynaud Disease General Medicine Toes Botulinum toxin body regions Raynaud's phenomenon 030220 oncology & carcinogenesis business Botulinum toxin type medicine.drug |
| Zdroj: | Dermatologic Therapy, 33(6):e14182. Wiley-Blackwell Publishing Ltd Dermatologic Therapy, 33(6). WILEY |
| ISSN: | 1396-0296 |
| Popis: | Raynaud's phenomenon is a vasospastic disorder clinically characterized by cold or stress-induced discoloration of the skin, pain and ulcers of the fingers or toes. Although this phenomenon might be self-limiting, there is a subgroup of patients requiring a therapeutic approach. The majority of patients do well on conservative measures; however, there is also a subgroup requiring systemic treatment. The efficacy of these systemic treatments is currently not thoroughly investigated. Furthermore, no uniform guidelines exist regarding the choice for a treatment option. In the past several years, several reports have shown the benefits of botulinum toxin for the treatment of Raynaud's phenomenon. In this case series, we report our experience with botulinum toxin type A in the treatment of Raynaud's phenomenon. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|